BRIEF published on 01/24/2025 at 12:35, 1 year 6 months ago Moderna Secures EU Tender for mRNA COVID-19 Vaccine Supply COVID-19 Moderna MRNA Vaccine Spikevax EU Tender
PRESS RELEASE published on 01/24/2025 at 12:30, 1 year 6 months ago Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union Moderna awarded tender to supply mRNA COVID-19 vaccine in EU, Norway, and North Macedonia, offering diverse formats like prefilled syringes. Enhancing vaccination campaigns with efficient options COVID-19 Moderna MRNA Vaccine Vaccination Campaigns Prefilled Syringes
BRIEF published on 01/17/2025 at 22:33, 1 year 6 months ago Moderna fait progresser le développement d'un vaccin antigrippal à base d'ARNm Essais Cliniques Vaccins À ARNm Moderne Grippe Financement BARDA
BRIEF published on 01/17/2025 at 22:33, 1 year 6 months ago Moderna Advances mRNA-Based Influenza Vaccine Development Clinical Trials Moderna MRNA Vaccines BARDA Funding Influenza
PRESS RELEASE published on 01/17/2025 at 22:28, 1 year 6 months ago Moderna Announces Updates on Pandemic Influenza Program Moderna announces ongoing support from HHS to accelerate mRNA-based pandemic influenza vaccines development. Award received through BARDA-funded RRPV Consortium Moderna MRNA BARDA HHS Pandemic Influenza Vaccines
BRIEF published on 01/13/2025 at 13:05, 1 year 7 months ago Moderna présente ses orientations stratégiques lors de la conférence JP Morgan Healthcare Approbations De Vaccins Finances Moderna Prévisions De Revenus Pour 2025 Plan De Réduction Des Coûts Étapes Clés Du Pipeline
BRIEF published on 01/13/2025 at 13:05, 1 year 7 months ago Moderna Outlines Strategic Moves at J.P. Morgan Healthcare Conference Cost Reduction Plan Vaccine Approvals Moderna Financials 2025 Revenue Forecast Pipeline Milestones
PRESS RELEASE published on 01/13/2025 at 13:00, 1 year 7 months ago Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference Moderna, Inc. announces 2024 financial achievements and 2025 projections with emphasis on revenue growth, cost reductions, and pipeline milestones including COVID-19 and flu vaccines Revenue Growth Financial Updates Moderna Cost Reductions Pipeline Milestones
BRIEF published on 11/25/2024 at 13:05, 1 year 8 months ago Moderna to Present at December 2024 Investor Conferences Investor Conferences Healthcare Webcast MRNA Technology Moderna
BRIEF published on 11/25/2024 at 13:05, 1 year 8 months ago Moderna présentera ses résultats financiers lors des conférences d'investisseurs de décembre 2024 Webcast Soins De Santé Conférences D'investisseurs Moderne Technologie De L'ARNm
Published on 08/13/2026 at 19:55, 1 hour 57 minutes ago NuRAN Wireless Receives Nasdaq Approval to List on The Nasdaq Capital Market; Trading Expected to Commence August 17, 2026 and C$7.6 Million Financing to Close August 14, 2026
Published on 08/13/2026 at 17:55, 3 hours 57 minutes ago Alset AI Announces Agreement to Sell 9.9% Interest in Lyken AI Computing to FingerMotion
Published on 08/13/2026 at 14:31, 7 hours 21 minutes ago Wi2Wi Announces Strategic Equipment Investments to Expand Production Capacity
Published on 08/13/2026 at 14:15, 7 hours 37 minutes ago Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
Published on 08/13/2026 at 14:00, 7 hours 52 minutes ago AEONIAN Expands Koocanusa Copper Project to Approximately 412 Km(2); Fieldwork Underway Across Four New Target Areas
Published on 08/13/2026 at 18:17, 3 hours 35 minutes ago EQS-Adhoc: Energiekontor AG: Energiekontor adjusts earnings guidance for the 2026 financial year
Published on 08/13/2026 at 18:00, 3 hours 52 minutes ago Deutsche EuroShop reports good operational performance in the first half of 2026 and confirms its forecast
Published on 08/13/2026 at 17:50, 4 hours 2 minutes ago EQS-Adhoc: NFON AG updates guidance for the 2026 financial year
Published on 08/13/2026 at 17:23, 4 hours 29 minutes ago EQS-Adhoc: Sirma Group JSC: Signing of Agreements to Acquire a Majority Stake in Jucari Global Pty Ltd
Published on 08/13/2026 at 18:00, 3 hours 52 minutes ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 2 days 4 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 2 days 4 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 3 days 3 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 3 days 3 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
